These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Importance of red cell labelling with radiochrome 51 in hemolytic anemia (apropos of 50 cases)]. Berthoux F; Barbier Y; Viala JJ; Berger M Lyon Med; 1968 Oct; 220(42):915-50. PubMed ID: 5742622 [No Abstract] [Full Text] [Related]
6. The spleen and haemolytic disorders. Bowdler AJ Clin Haematol; 1975 Feb; 4(1):231-46. PubMed ID: 1102183 [No Abstract] [Full Text] [Related]
7. [Practical value of the study of erythrocyte kinetics by in vitro labelling with Cr 51 in autoimmune hemolytic anemia]. Habibi B; Najean Y Presse Med (1893); 1971 Apr; 79(19):857-62. PubMed ID: 5576497 [No Abstract] [Full Text] [Related]
8. [Erythrocyte life span and surface activity measurement with Cr 51 in hemolytic anemias: before and after treatment]. Gehrmann G; Grobel P Nucl Med (Stuttg); 1963; 2():Suppl 1:217-23. PubMed ID: 5900115 [No Abstract] [Full Text] [Related]
9. Life-span and organ sequestration of the red cells in pyruvate kinase deficiency. Nathan DG; Oski FA; Miller DR; Gardner FH N Engl J Med; 1968 Jan; 278(2):73-81. PubMed ID: 5634483 [No Abstract] [Full Text] [Related]
10. Heparin and hemolytic anemia. Frimmer D; Creger WP Am J Med Sci; 1970 Jun; 259(6):412-8. PubMed ID: 5422285 [No Abstract] [Full Text] [Related]
11. Results of splenectomy in hemolytic syndromes on the basis of clinical, hematologic and isotope indications. Rudowski W; Pawelski S; Konopka L; Kwietniak K; Zdiechowska H; Rechowicz K Pol Med J; 1968; 7(3):661-70. PubMed ID: 5669708 [No Abstract] [Full Text] [Related]
12. Studies of splenic function by means of radioisotope labelled red cells. Szur L; Marsh GW; Pettit JE Br J Haematol; 1972 Sep; 23():Suppl:183-99. PubMed ID: 4567190 [No Abstract] [Full Text] [Related]
13. [The evaluation of hemocatheresis by means of erythrocytes labeled with Cr51 as a test for selection of hemolytic anemia patients to undergo splenectomy]. Spinelli Ressi F Haematol Lat; 1967; 10(4):381-90. PubMed ID: 5593507 [No Abstract] [Full Text] [Related]
14. [The determination of the site of erythrocyte destruction in hemolytic diseases with the aid of radioisotopes]. Kuba J; Cíhal K Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(2):197-208. PubMed ID: 4168344 [No Abstract] [Full Text] [Related]
15. [THE LOCALIZATION OF ERYTHROCYTE DEGRADATION IN AUTOIMMUNE HEMOLYTIC ANEMIAS. STUDIES WITH CR51]. HEIMPEL H; SCHUBOTHE H Blut; 1964 Nov; 10():306-18. PubMed ID: 14280264 [No Abstract] [Full Text] [Related]
16. The use of radioactive isotopes in the investigation of blood disorders. Blackburn EK Practitioner; 1971 Sep; 207(239):282-90. PubMed ID: 5315331 [No Abstract] [Full Text] [Related]
18. [Hemolytic anemias. On the therapy of hemolytic anemias with special reference to the problem of erythrocyte substitution]. Bube FW Internist (Berl); 1966 Jun; 7(6):309-13. PubMed ID: 4871113 [No Abstract] [Full Text] [Related]
19. Surface counting in the assessment of sites of red cell destruction. Szur L Br J Haematol; 1970 Jun; 18(6):591-6. PubMed ID: 4913771 [No Abstract] [Full Text] [Related]
20. [Measurement of the hemolysis coefficient and erythrocyte production with radiochromium-51. II. Applications to the diagnosis of hemolytic anemia]. Voisin D; Delmas-Marsalet Y; Sautière-Habay D; Goudemand M Lille Med; 1966 Nov; 11(9):978-86. PubMed ID: 5995723 [No Abstract] [Full Text] [Related] [Next] [New Search]